Guilandina bonduc L. possesses antioxidant activity and precludes ferric nitrilotriacetate (Fe-NTA) induced renal toxicity and tumor promotion response

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 28, Issue 2, 2009, Pages 163-175

  Kaur, Gurpreet ^a   Lone, Irshad A ^b   Athar, Mohammad ^a   Alam, M Sarwar ^b  

^a Department of Medical Elementology and Toxicology ^*  (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

Antioxidant; Ferric nitrilotriacetate; Guilandina bonduc; Oxidative stress; Tumor promotion

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; FREE RADICAL; GUILANDINA BONDUC EXTRACT; NITRIC OXIDE SYNTHASE; NITRILOTRIACETATE IRON; ORNITHINE DECARBOXYLASE; PLANT EXTRACT; SCAVENGER; SODIUM CHLORIDE; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DNA SYNTHESIS; FEMALE; INFLAMMATION; KIDNEY INJURY; MOUSE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TUMOR PROMOTION; UREA NITROGEN BLOOD LEVEL;

CAESALPINIA BONDUC; FABACEAE; MUS;

EID: 70350096102     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.v28.i2.80     Document Type: Article

References (33)

1. Awai M, Narasaki M, Yamanoi Y, Seno S. Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. A model of experimental hemochromatosis. Am J Pathol. 1979;95:663-672
2. Okada S, Midorikawa O. Induction of rat renal adenocarcinoma by ferric-nitrilotriacetate (Fe-NTA). Jpn Arch Int Med. 1982;29:485-491
3. Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med. 1996;20: 553-566
4. Toyokuni S, Uchida K, Okamato K, Nakakuki YH, Hiai H, Stadtman ER. Formation of 4-hydroxy- 2-nonenal-modified proteins in the renal proximal tubules of rats treated with renal carcinogen, ferric nitrilotriacetate. Proc Natl Acad Sci U S A. 1994;91:2616-2620
5. Toyokuni S, Sagripanti JL. DNA single and double- strand breaks produced by ferric nitrilotriacetate in relation to renal tubular carcinogenesis. Carcinogenesis. 1993;14:223-227
6. Inoue S, Kawanishi S. Hydroxyl radical production and human DNA damage induced by ferric nitrilotriacetate and hydrogen peroxide. Cancer Res. 1987;47:6522-6527
7. Huang MT, Newmark HL, Frenkel K. Inhibitory effects of curcumin on tumorigenesis in mice. J Cell Biochem. 1997;27:26-34.
8. Wood AW, Huang MT, Chang RL, Newmark HL, Lehr RF, Yagi H, Seyer JM, Jerina DM, Conney AH. Inhibition of mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols. Exceptional activity of ellagic acid. Proc Natl Acad Sci U S A. 1982;79:5513-5517
9. Neogi NC, Nayak KP. Biological investigation of Caesalpinia bonducella Flem Indian J Pharmacol. 1958;20:95-100.
10. Nakamura ES, Kurosaki F, Arisawa M, Mukainaka T, Takayasu J, Okuda M, Tokuda H, Nishino H, Pastore F. Cancer chemopreventive effects of a Brazilian folk medicine, Juca, on in vivo two-stage skin carcinogenesis. J Ethnopharmacol. 2002;81:135-137
11. Kirtikar KR, Basu BD. Indian medicinal plants. vol.2, 2nd ed. New Delhi: Periodical Express; 1975. p. 842-844, 894-5,.
12. Taga MS, Miller, EE, Pratt DE. Chia seeds as a source of natural lipid antioxidant. J Am Oil Chem Soc. 1984;61:928-931
13. Yen G, Chen H. Antioxidant activity of various tea extract in relation to their antimutagenicity. J Agric Food Chem. 1995;43:27-32.
14. Aruoma OI, Halliwell B. Action of hypochlorous acid on the antioxidant protective enzymes superoxide superoxide dismutase, catalase and glutathione peroxidase. Biochem J. 1987;248:973-976
15. Jollow DJ, Mitchell JR, Zampaglione N, Gillete JR. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4 bromobenzeneoxide as the hepatotoxic intermediate. Pharmacology. 1974;11:151-169
16. Habig WH, Pabst MJ, Jokoby WB. Glutathione Stransferase: the first enzymatic step in mercapturic acid formation. J Biol Chem. 1974;249:7130-7139
17. Mohandas J, Marshall JJ, Duggin GG, Horvath JS, Tiller D. Differential distribution of glutathione and glutathione related enzymes in rabbit kidney: possible implications in analgesic neuropathy. Cancer Res. 1984;44:5086-5091
18. Carlberg VM, Mannervik B. Glutathione reductase levels in rat brain. J Biol Chem. 1975;250:5475-5480
19. Claiborne A. Catalase activity. In: Greenwald RA., editor. CRC handbook of methods for oxygen radical research. Boca Raton: CRC Press; 1985. p 283-284
20. Wright JR, Colby HD, Miles PR. Cytosolic factors, which affect microsomal lipid peroxidation in lung and liver. Arch Biochem Biophys. 1981;206: 296-304.
21. Pick A, Keisari Y. Superoxide anion and H2O2 production by chemically elicited peritoneal macrophages-induction by multiple nonphagocytic stimulus. Cell Immunol. 1981;59:301-308
22. O'Brien TG, Simsiman RC, Boutwell RK. Induction of the polyamine-biosynthetic enzymes in mouse epidermis by tumor promoting agents. Cancer Res. 1975;35:1662-1670
23. Smart RC, Huang MT and Conney AH. Sn-1, 2-diacylglycerols mimic the effects of TPA in vivo by inducing biochemical changes associated with tumor promotion in mouse epidermis. Carcinogenesis. 1986;7:1865-1870
24. Cook JA, Gius D, Wink DA, Krishna MC, Russo A, Mitchell JB. Oxidative stress, redox, and the tumor microenvironment. Semin Radiat Oncol. 2004;14:259-266
25. Giri U, Iqbal M, Athar M. Copper-nitrilotriacetate (Cu-NTA) is a potent inducer of proliferative response both in liver and kidney but is a complete renal carcinogen. Int J Oncol. 1999;14:799-806.
26. Giri U, Iqbal M, Athar M. Potassium bromate (KBrO3) induces renal proliferative response and damage by elaborating oxidative stress. Cancer Lett. 1999;135:181-188
27. Kaur G, Lone IA, Athar M, Alam MS. Protective effect of Didymocarpus pedicellata on ferric nitrilotriacetate (Fe-NTA) induced renal oxidative stress and hyperproliferative response. Chem Biol Interact. 2007;165:33-44. (Pubitemid 44970450)
28. Ansar S, Iqbal M, Athar M. Nordihydroguairetic acid is a potent inhibitor of ferricnitrilotriacetate-mediated hepatic and renal toxicity, and renal tumour promotion, in mice. Carcinogenesis. 1999;20:599-606.
29. Rahman A, Ahmed S, Vasenwala SM, Athar M. Glyceryl trinitrate, a nitric oxide donor, abrogates ferric nitrilotriacetate-induced oxidative stress and renal damage. Arch Biochem Biophys. 2003;418:71-79
30. Hartwig A, Klyszcz-Nasko H, Schlepegrell R, Beyersmann D. Cellular damage by ferric nitrilotriacetate and ferric citrate in V79 cells: interrelationship between lipid peroxidation, DNA strand breaks and sister chromatid exchanges. Carcinogenesis. 1993;14:107-112
31. Min KS, Morishita F, Tetsuchikawahara N, Onosaka S. Induction of hepatic and renal metallothionein synthesis by ferric nitrilotriacetate in mice: the role of MT as an antioxidant. Toxicol Appl Pharmacol. 2005;204:9-17.
32. De Flora S, Ramel C. Mechanisms of inhibitors of mutagenesis and carcinogenesis. classification and overview. Mutat Res. 1998;202:285-306.
33. Chen L, Wang Y, Kairaitis LK, Wang Y, Zhang BH, Harris DC. Molecular mechanisms by which iron induces nitric oxide synthesis in cultured proximal tubule cells. Exp Nephrol. 2001;9:198-204.